Beyond statins: the role of ezetimibe in targeting residual risk.
29 August 2016 (13:10 - 13:25)
Organised by:
About the speaker
University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)
4 More presentations in this session
Doctor P. Ridker (Boston, US)
Professor E. Stroes (Amsterdam, NL)
Professor P. Libby (Boston, US)
Professor J. Deanfield (London, GB)
Access the full session
The Event
ESC Congress 2016
29 August 2016
13:10 CET
You may be interested in
Webinar
15 November 2021
Congress Presentation
Congress Presentation
